Haemonetics Corp (HAE)
77.89
-0.19
(-0.24%)
USD |
NYSE |
Oct 04, 16:00
77.85
-0.04
(-0.05%)
After-Hours: 20:00
Haemonetics SG&A Expense (TTM): 446.54M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 446.54M |
March 31, 2024 | 431.78M |
December 31, 2023 | 407.86M |
September 30, 2023 | 390.80M |
June 30, 2023 | 377.93M |
March 31, 2023 | 376.68M |
December 31, 2022 | 371.34M |
September 30, 2022 | 357.40M |
June 30, 2022 | 341.15M |
March 31, 2022 | 340.14M |
December 31, 2021 | 331.43M |
September 30, 2021 | 316.35M |
June 30, 2021 | 304.14M |
March 31, 2021 | 275.22M |
December 31, 2020 | 244.34M |
September 30, 2020 | 256.97M |
June 30, 2020 | 271.32M |
March 31, 2020 | 282.02M |
December 31, 2019 | 282.99M |
September 30, 2019 | 278.60M |
June 30, 2019 | 277.93M |
March 31, 2019 | 273.47M |
December 31, 2018 | 298.69M |
September 30, 2018 | 322.67M |
June 30, 2018 | 318.21M |
Date | Value |
---|---|
March 31, 2018 | 316.52M |
December 31, 2017 | 309.20M |
September 30, 2017 | 282.75M |
June 30, 2017 | 281.09M |
March 31, 2017 | 301.73M |
December 31, 2016 | 306.30M |
September 30, 2016 | 313.84M |
June 30, 2016 | 317.28M |
March 31, 2016 | 317.39M |
December 31, 2015 | 318.90M |
September 30, 2015 | 322.47M |
June 30, 2015 | 332.68M |
March 31, 2015 | 337.63M |
December 31, 2014 | 347.94M |
September 30, 2014 | 354.99M |
June 30, 2014 | 351.73M |
March 31, 2014 | 365.98M |
December 31, 2013 | 365.49M |
September 30, 2013 | 362.71M |
June 30, 2013 | 362.24M |
March 31, 2013 | 323.05M |
December 31, 2012 | 300.48M |
September 30, 2012 | 275.08M |
June 30, 2012 | 256.65M |
March 31, 2012 | 245.26M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
244.34M
Minimum
Dec 2020
446.54M
Maximum
Jun 2024
337.18M
Average
340.14M
Median
Mar 2022
SG&A Expense (TTM) Benchmarks
Boston Scientific Corp | 5.431B |
Globus Medical Inc | 887.75M |
Baxter International Inc | 3.953B |
Intuitive Surgical Inc | 2.036B |
Masimo Corp | 653.40M |